Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

OHIO-1 beta-lactamase resistant to mechanism-based inactivators.

FEMS microbiology letters - 1 Apr 1992

Bonomo R A, Currie-McCumber C, Shlaes D M

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Anti-Bacterial Agents
Share to beta-Lactamases
Share to Clavulanic Acid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Microbial

Share to Escherichia coli

Share to Plasmids

Share to Sequence Homology, Nucleic Acid

Source

Identifiers

PMID: 1320587
DOI: 10.1016/0378-1097(92)90545-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

OHIO-1 beta-lactamase resistant to mechanism-based inactivators.PMID 1320587Read ↗

Extended-spectrum beta-lactamases: the role of inhibitors in therapy.Semantic proximity Read ↗

Structural perspectives on clinical β-lactamase inhibitors: From mechanism to resistance.Semantic proximity Read ↗

Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.Semantic proximity Read ↗

Three Decades of β-Lactamase InhibitorsSemantic proximity Read ↗

Meeting notes from the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). New NNRTI resistance mutations.Semantic proximity Read ↗

Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directionsSemantic proximity Read ↗

[Resistance to protease inhibitors].Semantic proximity Read ↗

Construction and characterization of an OHIO-1 beta-lactamase bearing Met69Ile and Gly238Ser mutations.Semantic proximity Read ↗

Antibiotic resistance. Resistance mediated by inhibitor-resistant and extended-spectrum TEM and SHV beta-lactamases.Semantic proximity Read ↗

OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidime.Semantic proximity Read ↗

Tazobactam is a potent inactivator of selected inhibitor-resistant class A β-lactamasesSemantic proximity Read ↗

AmpC beta-lactamases.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.